Massachusetts state prison officials agreed to expand treatment for inmates with hepatitis C, in the first settlement among several class-action lawsuits accusing state prison systems of denying many prisoners access to costly drugs.
Drugmakers including Gilead Sciences Inc., AbbVie Inc. and Merck & Co. since 2013 have . . .